In a New Study, Treatment With JANUMET(R) (sitagliptin/metformin), Merck's ... - MarketWatch (press release) PDF Print
MarketWatch (press release)JANUMET is contraindicated in patients with renal disease, renal dysfunction, or abnormal creatinine clearance; and acute or chronic metabolic acidosis,

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.